Celiac disease and upper secondary school achievement in Sweden A retrospective cohort study.
Celiac disease
Follow-up
Gluten-free diet
Grades
School performance
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
12 Dec 2022
12 Dec 2022
Historique:
received:
31
08
2022
accepted:
24
11
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Both undiagnosed celiac disease and some chronic childhood diseases are associated with lower academic achievement. However, there is little knowledge of achievements in those diagnosed with celiac disease. Our aim was to investigate school achievements in upper secondary school among Swedish adolescents with celiac disease. We performed a retrospective cohort study using register data. We analyzed choice of upper secondary school program, completion of upper secondary school including achievements of basic eligibility for college/university, and final grade in individuals with celiac disease diagnosed before 15 years of age, born 1991-97. We compared with the Swedish population of the same birth years. Analyses were adjusted for sex, year of birth, living region at 17 years of age, and parental education as well as income. The cohort included 734 074 individuals, whereof 3 257 (62% females) with celiac disease. There was no significant difference in choice of upper secondary school program. No significant difference was found in completion or achieving basic eligibility for college/university in adjusted analyses. The mean final grade in the celiac disease group was 13.34 (standard deviation 4.85) compared to 12.78 (standard deviation 5.01) in the reference population (p < 0.001), out of a maximum of 20. The effect of celiac disease on final grade remained in adjusted analyses (p = 0.012). We found that diagnosed celiac disease does not negatively affect school achievements in upper secondary school. This finding suggests the diagnosis, treatment and follow-up programs of celiac disease could reverse potential deleterious academic processes.
Sections du résumé
BACKGROUND
BACKGROUND
Both undiagnosed celiac disease and some chronic childhood diseases are associated with lower academic achievement. However, there is little knowledge of achievements in those diagnosed with celiac disease. Our aim was to investigate school achievements in upper secondary school among Swedish adolescents with celiac disease.
METHODS
METHODS
We performed a retrospective cohort study using register data. We analyzed choice of upper secondary school program, completion of upper secondary school including achievements of basic eligibility for college/university, and final grade in individuals with celiac disease diagnosed before 15 years of age, born 1991-97. We compared with the Swedish population of the same birth years. Analyses were adjusted for sex, year of birth, living region at 17 years of age, and parental education as well as income.
RESULTS
RESULTS
The cohort included 734 074 individuals, whereof 3 257 (62% females) with celiac disease. There was no significant difference in choice of upper secondary school program. No significant difference was found in completion or achieving basic eligibility for college/university in adjusted analyses. The mean final grade in the celiac disease group was 13.34 (standard deviation 4.85) compared to 12.78 (standard deviation 5.01) in the reference population (p < 0.001), out of a maximum of 20. The effect of celiac disease on final grade remained in adjusted analyses (p = 0.012).
CONCLUSIONS
CONCLUSIONS
We found that diagnosed celiac disease does not negatively affect school achievements in upper secondary school. This finding suggests the diagnosis, treatment and follow-up programs of celiac disease could reverse potential deleterious academic processes.
Identifiants
pubmed: 36503420
doi: 10.1186/s12887-022-03773-6
pii: 10.1186/s12887-022-03773-6
pmc: PMC9743674
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
709Informations de copyright
© 2022. The Author(s).
Références
Acta Paediatr. 2012 Feb;101(2):185-91
pubmed: 21824189
BMC Psychiatry. 2016 Mar 15;16:64
pubmed: 26980092
Aliment Pharmacol Ther. 2014 Jul;40(2):160-70
pubmed: 24889390
Obstet Gynecol. 2011 Aug;118(2 Pt 1):201-208
pubmed: 21734618
Lancet. 2022 Jun 25;399(10344):2413-2426
pubmed: 35691302
Indian J Gastroenterol. 2021 Oct;40(5):453-462
pubmed: 34839445
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60
pubmed: 22197856
Arch Dis Child. 2018 Feb;103(2):143-148
pubmed: 28844065
Gastroenterology. 2020 Jun;158(8):2112-2122
pubmed: 32088203
Am J Gastroenterol. 2014 Sep;109(9):1304-11
pubmed: 24980880
Clin Gastroenterol Hepatol. 2020 Mar;18(3):562-573
pubmed: 31173891
J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):170-6
pubmed: 19516192
Matern Child Health J. 2017 Feb;21(2):283-289
pubmed: 27449779
J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):54-60
pubmed: 19644397
J Sch Health. 2005 Sep;75(7):255-66
pubmed: 16102088
Scand J Gastroenterol. 2005 Dec;40(12):1407-12
pubmed: 16293555
Psychol Rep. 2006 Apr;98(2):318-22
pubmed: 16796083
Clin Gastroenterol Hepatol. 2022 May;20(5):1068-1076.e6
pubmed: 34509642
Aliment Pharmacol Ther. 2009 Aug 15;30(4):315-30
pubmed: 19485977
Acta Paediatr. 2021 Apr;110(4):1346-1352
pubmed: 32885467
J Sch Nurs. 2020 Feb;36(1):61-78
pubmed: 30786840
Pediatrics. 2001 Aug;108(2):E35
pubmed: 11483845
Gut. 2016 Aug;65(8):1242-51
pubmed: 27196596
J Pediatr. 2011 Mar;158(3):463-466.e5
pubmed: 20870245
Int J Epidemiol. 2016 Aug;45(4):1075-1075g
pubmed: 27170765
JAMA. 2020 Apr 7;323(13):1277-1285
pubmed: 32259229
Gut. 2014 Aug;63(8):1210-28
pubmed: 24917550
Dig Dis Sci. 2018 Jun;63(6):1438-1448
pubmed: 29387990
Curr Pain Headache Rep. 2017 Jul;21(7):31
pubmed: 28551735
BMC Gastroenterol. 2017 Dec 11;17(1):156
pubmed: 29228908
Diabetologia. 2013 Jun;56(6):1254-62
pubmed: 23435847